NCT05514132 2026-03-09A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid TumoursAstraZenecaPhase 1 Active not recruiting14 enrolled
NCT06795412 2026-03-06Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid TumorsPyxis Oncology, IncPhase 1/2 Recruiting220 enrolled